BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17112413)

  • 21. Prolonged stability by cyclization: Macrocyclic phosphino dipeptide isostere inhibitors of beta-secretase (BACE1).
    Huber T; Manzenrieder F; Kuttruff CA; Dorner-Ciossek C; Kessler H
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4427-31. PubMed ID: 19523824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Macrocyclic inhibitors of beta-secretase: functional activity in an animal model.
    Stachel SJ; Coburn CA; Sankaranarayanan S; Price EA; Wu G; Crouthamel M; Pietrak BL; Huang Q; Lineberger J; Espeseth AS; Jin L; Ellis J; Holloway MK; Munshi S; Allison T; Hazuda D; Simon AJ; Graham SL; Vacca JP
    J Med Chem; 2006 Oct; 49(21):6147-50. PubMed ID: 17034118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of aminoheterocycles as a novel beta-secretase inhibitor class: pH dependence on binding activity part 1.
    Stachel SJ; Coburn CA; Rush D; Jones KL; Zhu H; Rajapakse H; Graham SL; Simon A; Katharine Holloway M; Allison TJ; Munshi SK; Espeseth AS; Zuck P; Colussi D; Wolfe A; Pietrak BL; Lai MT; Vacca JP
    Bioorg Med Chem Lett; 2009 Jun; 19(11):2977-80. PubMed ID: 19409780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BACE1 inhibitors: optimization by replacing the P1' residue with non-acidic moiety.
    Hamada Y; Abdel-Rahman H; Yamani A; Nguyen JT; Stochaj M; Hidaka K; Kimura T; Hayashi Y; Saito K; Ishiura S; Kiso Y
    Bioorg Med Chem Lett; 2008 Mar; 18(5):1649-53. PubMed ID: 18249539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological evidences for DFK167-sensitive presenilin-independent gamma-secretase-like activity.
    Sevalle J; Ayral E; Hernandez JF; Martinez J; Checler F
    J Neurochem; 2009 Jul; 110(1):275-83. PubMed ID: 19457123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of gamma-secretase activity by helical beta-peptide foldamers.
    Imamura Y; Watanabe N; Umezawa N; Iwatsubo T; Kato N; Tomita T; Higuchi T
    J Am Chem Soc; 2009 Jun; 131(21):7353-9. PubMed ID: 19432477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional plasticity in the substrate binding site of beta-secretase.
    Gorfe AA; Caflisch A
    Structure; 2005 Oct; 13(10):1487-98. PubMed ID: 16216580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In silico multi-filter screening approaches for developing novel beta-secretase inhibitors.
    Fujimoto T; Matsushita Y; Gouda H; Yamaotsu N; Hirono S
    Bioorg Med Chem Lett; 2008 May; 18(9):2771-5. PubMed ID: 18434150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a small molecule nonpeptide active site beta-secretase inhibitor that displays a nontraditional binding mode for aspartyl proteases.
    Coburn CA; Stachel SJ; Li YM; Rush DM; Steele TG; Chen-Dodson E; Holloway MK; Xu M; Huang Q; Lai MT; DiMuzio J; Crouthamel MC; Shi XP; Sardana V; Chen Z; Munshi S; Kuo L; Makara GM; Annis DA; Tadikonda PK; Nash HM; Vacca JP; Wang T
    J Med Chem; 2004 Dec; 47(25):6117-9. PubMed ID: 15566281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design of potent inhibitors of human beta-secretase. Part 2.
    Freskos JN; Fobian YM; Benson TE; Moon JB; Bienkowski MJ; Brown DL; Emmons TL; Heintz R; Laborde A; McDonald JJ; Mischke BV; Molyneaux JM; Mullins PB; Bryan Prince D; Paddock DJ; Tomasselli AG; Winterrowd G
    Bioorg Med Chem Lett; 2007 Jan; 17(1):78-81. PubMed ID: 17049233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Promoting alpha-secretase cleavage of beta-amyloid with engineered proteolytic antibody fragments.
    Kasturirangan S; Brune D; Sierks M
    Biotechnol Prog; 2009; 25(4):1054-63. PubMed ID: 19572401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Purification, pharmacological modulation, and biochemical characterization of interactors of endogenous human gamma-secretase.
    Winkler E; Hobson S; Fukumori A; Dümpelfeld B; Luebbers T; Baumann K; Haass C; Hopf C; Steiner H
    Biochemistry; 2009 Feb; 48(6):1183-97. PubMed ID: 19159235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis, and crystal structure of hydroxyethyl secondary amine-based peptidomimetic inhibitors of human beta-secretase.
    Maillard MC; Hom RK; Benson TE; Moon JB; Mamo S; Bienkowski M; Tomasselli AG; Woods DD; Prince DB; Paddock DJ; Emmons TL; Tucker JA; Dappen MS; Brogley L; Thorsett ED; Jewett N; Sinha S; John V
    J Med Chem; 2007 Feb; 50(4):776-81. PubMed ID: 17300163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acylguanidines as small-molecule beta-secretase inhibitors.
    Cole DC; Manas ES; Stock JR; Condon JS; Jennings LD; Aulabaugh A; Chopra R; Cowling R; Ellingboe JW; Fan KY; Harrison BL; Hu Y; Jacobsen S; Jin G; Lin L; Lovering FE; Malamas MS; Stahl ML; Strand J; Sukhdeo MN; Svenson K; Turner MJ; Wagner E; Wu J; Zhou P; Bard J
    J Med Chem; 2006 Oct; 49(21):6158-61. PubMed ID: 17034121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery and SAR of isonicotinamide BACE-1 inhibitors that bind beta-secretase in a N-terminal 10s-loop down conformation.
    Stauffer SR; Stanton MG; Gregro AR; Steinbeiser MA; Shaffer JR; Nantermet PG; Barrow JC; Rittle KE; Collusi D; Espeseth AS; Lai MT; Pietrak BL; Holloway MK; McGaughey GB; Munshi SK; Hochman JH; Simon AJ; Selnick HG; Graham SL; Vacca JP
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1788-92. PubMed ID: 17257835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Truncation and optimisation of peptide inhibitors of cyclin-dependent kinase 2-cyclin a through structure-guided design.
    Kontopidis G; Andrews MJ; McInnes C; Plater A; Innes L; Renachowski S; Cowan A; Fischer PM
    ChemMedChem; 2009 Jul; 4(7):1120-8. PubMed ID: 19472269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis, and X-ray structure of potent memapsin 2 (beta-secretase) inhibitors with isophthalamide derivatives as the P2-P3-ligands.
    Ghosh AK; Kumaragurubaran N; Hong L; Kulkarni SS; Xu X; Chang W; Weerasena V; Turner R; Koelsch G; Bilcer G; Tang J
    J Med Chem; 2007 May; 50(10):2399-407. PubMed ID: 17432843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. P-glycoprotein efflux and other factors limit brain amyloid beta reduction by beta-site amyloid precursor protein-cleaving enzyme 1 inhibitors in mice.
    Meredith JE; Thompson LA; Toyn JH; Marcin L; Barten DM; Marcinkeviciene J; Kopcho L; Kim Y; Lin A; Guss V; Burton C; Iben L; Polson C; Cantone J; Ford M; Drexler D; Fiedler T; Lentz KA; Grace JE; Kolb J; Corsa J; Pierdomenico M; Jones K; Olson RE; Macor JE; Albright CF
    J Pharmacol Exp Ther; 2008 Aug; 326(2):502-13. PubMed ID: 18499745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secretase inhibitors and modulators for Alzheimer's disease treatment.
    Tomita T
    Expert Rev Neurother; 2009 May; 9(5):661-79. PubMed ID: 19402777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design of pentapeptidic BACE1 inhibitors with carboxylic acid bioisosteres at P1' and P4 positions.
    Tagad HD; Hamada Y; Nguyen JT; Hamada T; Abdel-Rahman H; Yamani A; Nagamine A; Ikari H; Igawa N; Hidaka K; Sohma Y; Kimura T; Kiso Y
    Bioorg Med Chem; 2010 May; 18(9):3175-86. PubMed ID: 20381362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.